A detailed history of Osborne Partners Capital Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Osborne Partners Capital Management, LLC holds 21,009 shares of JNJ stock, worth $3.4 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
21,009
Previous 23,064 8.91%
Holding current value
$3.4 Million
Previous $3.65 Million 15.84%
% of portfolio
0.19%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$144.38 - $157.78 $296,700 - $324,237
-2,055 Reduced 8.91%
21,009 $3.07 Million
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $624,139 - $654,377
-4,021 Reduced 14.85%
23,064 $3.65 Million
Q4 2023

Jan 22, 2024

SELL
$145.6 - $158.88 $171,516 - $187,160
-1,178 Reduced 4.17%
27,085 $4.25 Million
Q3 2023

Oct 26, 2023

SELL
$155.75 - $174.48 $98,278 - $110,096
-631 Reduced 2.18%
28,263 $4.4 Million
Q2 2023

Jul 20, 2023

SELL
$154.35 - $166.11 $57,881 - $62,291
-375 Reduced 1.28%
28,894 $4.78 Million
Q1 2023

Apr 24, 2023

BUY
$151.05 - $180.26 $47,278 - $56,421
313 Added 1.08%
29,269 $4.54 Million
Q4 2022

Jan 24, 2023

SELL
$160.2 - $179.79 $50,142 - $56,274
-313 Reduced 1.07%
28,956 $0
Q3 2022

Oct 27, 2022

BUY
$161.33 - $179.52 $70,178 - $78,091
435 Added 1.51%
29,269 $4.78 Million
Q2 2022

Aug 01, 2022

BUY
$168.19 - $186.01 $945,564 - $1.05 Million
5,622 Added 24.22%
28,834 $5.12 Million
Q1 2022

May 05, 2022

SELL
$158.14 - $179.59 $436,624 - $495,847
-2,761 Reduced 10.63%
23,212 $4.11 Million
Q4 2021

Jan 31, 2022

SELL
$155.93 - $173.01 $112,269 - $124,567
-720 Reduced 2.7%
25,973 $4.44 Million
Q3 2021

Oct 25, 2021

BUY
$161.5 - $179.47 $8,559 - $9,511
53 Added 0.2%
26,693 $4.31 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $248,948 - $267,040
-1,561 Reduced 5.54%
26,640 $4.39 Million
Q1 2021

Aug 09, 2021

SELL
$153.07 - $170.48 $1.77 Million - $1.98 Million
-11,594 Reduced 29.13%
28,201 $4.64 Million
Q1 2021

Apr 27, 2021

SELL
$153.07 - $170.48 $86,331 - $96,150
-564 Reduced 1.4%
39,795 $6.54 Million
Q4 2020

Feb 01, 2021

BUY
$137.11 - $157.38 $91,863 - $105,444
670 Added 1.69%
40,359 $6.35 Million
Q3 2020

Oct 28, 2020

SELL
$140.38 - $153.83 $147,399 - $161,521
-1,050 Reduced 2.58%
39,689 $5.91 Million
Q2 2020

Jul 23, 2020

SELL
$128.81 - $155.51 $85,916 - $103,725
-667 Reduced 1.61%
40,739 $5.73 Million
Q1 2020

Apr 29, 2020

SELL
$111.14 - $153.99 $72,241 - $100,093
-650 Reduced 1.55%
41,406 $5.43 Million
Q4 2019

Jan 27, 2020

SELL
$127.5 - $146.44 $904,740 - $1.04 Million
-7,096 Reduced 14.44%
42,056 $6.14 Million
Q3 2019

Oct 25, 2019

SELL
$126.95 - $142.14 $19,677 - $22,031
-155 Reduced 0.31%
49,152 $6.36 Million
Q2 2019

Jul 18, 2019

SELL
$131.15 - $144.24 $130,231 - $143,230
-993 Reduced 1.97%
49,307 $6.87 Million
Q1 2019

Apr 24, 2019

SELL
$125.72 - $139.79 $1.45 Million - $1.61 Million
-11,522 Reduced 18.64%
50,300 $7.03 Million
Q4 2018

Jan 28, 2019

SELL
$122.84 - $147.84 $185,611 - $223,386
-1,511 Reduced 2.39%
61,822 $7.98 Million
Q3 2018

Oct 26, 2018

SELL
$121.58 - $142.88 $125,348 - $147,309
-1,031 Reduced 1.6%
63,333 $8.75 Million
Q2 2018

Jul 19, 2018

BUY
$119.4 - $131.76 $1.14 Million - $1.26 Million
9,543 Added 17.41%
64,364 $7.81 Million
Q1 2018

Apr 19, 2018

SELL
$125.1 - $148.14 $87,444 - $103,549
-699 Reduced 1.26%
54,821 $7.03 Million
Q4 2017

Jan 25, 2018

SELL
$131.22 - $143.62 $164,156 - $179,668
-1,251 Reduced 2.2%
55,520 $7.76 Million
Q3 2017

Oct 19, 2017

BUY
$129.47 - $135.38 $7.35 Million - $7.69 Million
56,771
56,771 $7.38 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Osborne Partners Capital Management, LLC Portfolio

Follow Osborne Partners Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.